Your browser doesn't support javascript.
loading
Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed.
Nummi, Vuokko; Lehtinen, Elina; Mäkipernaa, Anne; Szanto, Timea; Lassila, Riitta.
Affiliation
  • Nummi V; Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Lehtinen E; Coagulation Disorder Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Mäkipernaa A; Coagulation Disorder Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Szanto T; Coagulation Disorder Unit, Department of Hematology and Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
  • Lassila R; Coagulation Disorder Unit, Department of Clinical Chemistry, HUSLAB Laboratory Services, Helsinki University Hospital, Helsinki, Finland.
Haemophilia ; 25(4): e291-e293, 2019 Jul.
Article in En | MEDLINE | ID: mdl-31050121
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins, Intravenous / Von Willebrand Disease, Type 3 / Gastrointestinal Hemorrhage / Isoantibodies Limits: Female / Humans / Middle aged Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulins, Intravenous / Von Willebrand Disease, Type 3 / Gastrointestinal Hemorrhage / Isoantibodies Limits: Female / Humans / Middle aged Language: En Journal: Haemophilia Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: